Publications by authors named "Virginia Robles Alonso"

Claim this Profile
D
Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study.
Elena Céspedes-Martínez, Virginia Robles-Alonso, Xavier Serra-Ruiz, Claudia Herrera-De Guise, Luis Mayorga-Ayala

Crohns Colitis 360· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
Laura Palomino, Marta Velasco Rodríguez-Belvís, María José Casanova, Eduardo Leo-Carnerero, Cristina Calviño-Suárez, Virginia Robles Alonso

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.
Virginia Robles-Alonso, Roser Solans, Ernesto Lastiri, Xavier Serra, Elena Céspedes-Martínez

Gastroenterol Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History.
Eduard Brunet-Mas, Anna Selva, Francesc Bas-Cutrina, Anna Brujats, Berta Caballol, Virginia Robles-Alonso

Clin Transl Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK Inhibitors for Autoimmune Hepatitis: One Swallow Does Not Make a Summer.
Juan Carlos Ruiz-Cobo, Lourdes Ruiz-Ortega, Virginia Robles-Alonso, Mar Riveiro-Barciela

Liver Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Mar Riveiro-Barciela, Luisa Roade, Joan Martínez-Camprecios, Judit Vidal-González, Basilio Rodríguez-Diez, Virginia Robles-Alonso

Gastroenterol Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital.
Elena Céspedes Martínez, Virginia Robles Alonso, Claudia Herrera-De Guise, Luis Mayorga, Francesc Casellas

Rev Esp Enferm Dig· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
Claudia Herrera-deGuise, Encarna Varela, Guillaume Sarrabayrouse, Marta Pozuelo Del Río, Virginia Robles Alonso

Inflamm Bowel Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak.
Claudia Herrera-de Guise, Luis Fernando Mayorga Ayala, Xavier Serra Ruiz, Virginia Robles Alonso, Natalia Borruel Sainz

Rev Esp Enferm Dig· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
María Chaparro, Iria Baston-Rey, Estela Fernández-Salgado, Javier González García, Laura Ramos, Francisco Javier García-Alonso, Virginia Robles Alonso

Inflamm Bowel Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
María Chaparro, Iria Baston-Rey, Estela Fernández Salgado, Javier González García, Laura Ramos, Francisco Javier García Alonso, Virginia Robles Alonso

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management.
Virginia Robles-Alonso, Fernando Martínez-Valle, Natalia Borruel

Front Med (Lausanne)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of a Telephone-Based Motivational Intervention for Smoking Cessation in Patients With Crohn Disease: A Randomized, Open-Label, Controlled Clinical Trial.
Ester Navarro Correal, Francesc Casellas Jorda, Natalia Borruel Sainz, Virginia Robles Alonso, Claudia Herrera de Guise

Gastroenterol Nurs· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of long-term quality of life in Crohn's disease patients receiving ustekinumab.
Miquel Marquès-Camí, Virginia Robles Alonso, Natalia Borruel, Claudia Herrera de Guise, Luis Mayorga

Rev Esp Enferm Dig· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From basic to applied research: lessons from the human microbiome projects.
Virginia Robles-Alonso, Francisco Guarner

J Clin Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Progress in the knowledge of the intestinal human microbiota].
Virginia Robles-Alonso, Francisco Guarner

Nutr Hosp· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking the gut microbiota to human health.
Virginia Robles Alonso, Francisco Guarner

Br J Nutr· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis